Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Clinical trial NCT04938609 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04938609
Sponsor: Providence Health & Services
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2022-01-11
Primary completion: 2027-01-11
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.